NovoLog and Ramucirumab Intravenous
Determining the interaction of NovoLog and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: NovoLog, NovoLog FlexPen, NovoLog PenFill, Fiasp, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Novolog
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog-Ranexa
- NovoLog-Ranibizumab
- NovoLog-Ranibizumab Intraocular
- NovoLog-Ranibizumab ophthalmic
- NovoLog-Ranitidine
- NovoLog-Ranitidine Capsule
- Ramucirumab Intravenous-NovoLog FlexPen
- Ramucirumab Intravenous-Novolog Injection
- Ramucirumab Intravenous-NovoLog Mix 70/30
- Ramucirumab Intravenous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Ramucirumab Intravenous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Ramucirumab Intravenous-NovoLog Mix 70/30 FlexPen